36530928|t|Identification of Sex-Specific Genetic Variants Associated With Tau PET.
36530928|a|Background and Objectives: Important sex differences exist in tau pathology along the Alzheimer disease (AD) continuum, with women showing enhanced tau deposition compared with men, especially during the mild cognitive impairment (MCI) phase. This study aims to identify specific genetic variants associated with sex differences in regional tau aggregation, as measured with PET. Methods: Four hundred ninety-three participants (women, n = 246; men, n = 247) who self-identified as White from the AD Neuroimaging Initiative study, with genotyping data and 18F-Flortaucipir tau PET data, were included irrespective of clinical diagnosis (cognitively normal [CN], MCI, and AD). We focused on the genetic variants within 10 genes previously shown to have sex-dependent effects on AD to reduce the burden of multiple comparisons: BIN1, MS4A6A, DNAJA2, FERMT2, APOC1, APOC1P1, FAM193B, C2orf47, TYW5, and CR1. Multivariate analysis of variance was applied to identify genetic variants associated with tau PET data in 3 regions of interests (composite regions of Braak I, Braak III/IV, and Braak V/VI stages) in women and men separately. We controlled for age, scanner manufacture, amyloid status, APOE epsilon4 carriership, diagnosis (CN vs MCI vs AD), and the first 10 genetic principal components to adjust for population stratification. Results: We identified 3 genetic loci within 3 different genes associated with tau deposits specifically in women: rs79711283 within DNAJA2, rs113357081 within FERMT2, and rs74614106 within TYW5. In men, we also identified 3 loci within CR1 associated with tau deposits: rs115096248, rs113698814, and rs78150633. Discussion: Our findings revealed sex-specific genetic variants associated with tau deposition independent of APOE epsilon4, amyloid status, and clinical diagnosis. These results provide potential molecular targets for understanding the mechanism of sex-specific tau aggregation and developing sex-specific gene-guided precision prevention or therapeutic interventions for AD.
36530928	135	138	tau	Gene	4137
36530928	159	176	Alzheimer disease	Disease	MESH:D000544
36530928	178	180	AD	Disease	MESH:D000544
36530928	198	203	women	Species	9606
36530928	221	224	tau	Gene	4137
36530928	250	253	men	Species	9606
36530928	282	302	cognitive impairment	Disease	MESH:D003072
36530928	304	307	MCI	Disease	MESH:D060825
36530928	502	507	women	Species	9606
36530928	518	521	men	Species	9606
36530928	570	572	AD	Disease	MESH:D000544
36530928	629	645	18F-Flortaucipir	Chemical	MESH:C000591008
36530928	735	738	MCI	Disease	MESH:D060825
36530928	744	746	AD	Disease	MESH:D000544
36530928	850	852	AD	Disease	MESH:D000544
36530928	899	903	BIN1	Gene	274
36530928	905	911	MS4A6A	Gene	64231
36530928	913	919	DNAJA2	Gene	10294
36530928	921	927	FERMT2	Gene	10979
36530928	929	934	APOC1	Gene	341
36530928	936	943	APOC1P1	Gene	342
36530928	945	952	FAM193B	Gene	54540
36530928	954	961	C2orf47	Gene	79568
36530928	963	967	TYW5	Gene	129450
36530928	973	976	CR1	Gene	1378
36530928	1179	1184	women	Species	9606
36530928	1189	1192	men	Species	9606
36530928	1249	1256	amyloid	Disease	MESH:C000718787
36530928	1309	1312	MCI	Disease	MESH:D060825
36530928	1316	1318	AD	Disease	MESH:D000544
36530928	1487	1499	tau deposits	Disease	MESH:C536599
36530928	1516	1521	women	Species	9606
36530928	1523	1533	rs79711283	SNP	tmVar:rs79711283;VariantGroup:4;CorrespondingGene:10294;RS#:79711283;CorrespondingSpecies:9606
36530928	1541	1547	DNAJA2	Gene	10294
36530928	1549	1560	rs113357081	SNP	tmVar:rs113357081;VariantGroup:0;CorrespondingGene:10979;RS#:113357081;CorrespondingSpecies:9606
36530928	1568	1574	FERMT2	Gene	10979
36530928	1580	1590	rs74614106	SNP	tmVar:rs74614106;VariantGroup:2;CorrespondingGene:129450;RS#:74614106;CorrespondingSpecies:9606
36530928	1598	1602	TYW5	Gene	129450
36530928	1607	1610	men	Species	9606
36530928	1645	1648	CR1	Gene	1378
36530928	1665	1677	tau deposits	Disease	MESH:C536599
36530928	1679	1690	rs115096248	SNP	tmVar:rs115096248;VariantGroup:3;CorrespondingGene:1378;RS#:115096248;CorrespondingSpecies:9606
36530928	1692	1703	rs113698814	SNP	tmVar:rs113698814;VariantGroup:5;CorrespondingGene:1378;RS#:113698814;CorrespondingSpecies:9606
36530928	1709	1719	rs78150633	SNP	tmVar:rs78150633;VariantGroup:1;CorrespondingGene:1378;RS#:78150633;CorrespondingSpecies:9606
36530928	1801	1804	tau	Gene	4137
36530928	1846	1853	amyloid	Disease	MESH:C000718787
36530928	2094	2096	AD	Disease	MESH:D000544
36530928	Association	MESH:C536599	10294
36530928	Association	MESH:C536599	RS#:79711283;CorrespondingGene:10294
36530928	Association	MESH:C536599	RS#:113357081;CorrespondingGene:10979
36530928	Association	MESH:D000544	79568
36530928	Association	MESH:D000544	274
36530928	Association	MESH:C536599	RS#:74614106;CorrespondingGene:129450
36530928	Association	MESH:D000544	54540
36530928	Association	MESH:D060825	4137
36530928	Association	MESH:C536599	129450
36530928	Association	MESH:D000544	1378
36530928	Association	MESH:C536599	RS#:115096248;CorrespondingGene:1378
36530928	Association	MESH:C536599	10979
36530928	Association	MESH:D000544	342
36530928	Association	MESH:D000544	64231
36530928	Association	MESH:D003072	4137
36530928	Association	MESH:D000544	341
36530928	Association	MESH:D000544	4137
36530928	Association	MESH:C536599	10294
36530928	Association	MESH:C536599	10979
36530928	Association	MESH:C536599	129450
36530928	Association	MESH:C536599	1378

